| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.8 |